• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自反应性 CXCR6+CD8 T 细胞导致 NASH 肝脏免疫病理。

Auto-aggressive CXCR6 CD8 T cells cause liver immune pathology in NASH.

机构信息

Institute of Molecular Immunology and Experimental Oncology, School of Medicine, Technical University of Munich (TUM), Munich, Germany.

Institute of Chronic Inflammation and Cancer, German Cancer Research Center, Heidelberg, Germany.

出版信息

Nature. 2021 Apr;592(7854):444-449. doi: 10.1038/s41586-021-03233-8. Epub 2021 Mar 24.

DOI:10.1038/s41586-021-03233-8
PMID:33762736
Abstract

Nonalcoholic steatohepatitis (NASH) is a manifestation of systemic metabolic disease related to obesity, and causes liver disease and cancer. The accumulation of metabolites leads to cell stress and inflammation in the liver, but mechanistic understandings of liver damage in NASH are incomplete. Here, using a preclinical mouse model that displays key features of human NASH (hereafter, NASH mice), we found an indispensable role for T cells in liver immunopathology. We detected the hepatic accumulation of CD8 T cells with phenotypes that combined tissue residency (CXCR6) with effector (granzyme) and exhaustion (PD1) characteristics. Liver CXCR6 CD8 T cells were characterized by low activity of the FOXO1 transcription factor, and were abundant in NASH mice and in patients with NASH. Mechanistically, IL-15 induced FOXO1 downregulation and CXCR6 upregulation, which together rendered liver-resident CXCR6 CD8 T cells susceptible to metabolic stimuli (including acetate and extracellular ATP) and collectively triggered auto-aggression. CXCR6 CD8 T cells from the livers of NASH mice or of patients with NASH had similar transcriptional signatures, and showed auto-aggressive killing of cells in an MHC-class-I-independent fashion after signalling through P2X7 purinergic receptors. This killing by auto-aggressive CD8 T cells fundamentally differed from that by antigen-specific cells, which mechanistically distinguishes auto-aggressive and protective T cell immunity.

摘要

非酒精性脂肪性肝炎(NASH)是一种与肥胖相关的全身性代谢性疾病的表现形式,可导致肝脏疾病和癌症。代谢物的积累导致肝脏细胞应激和炎症,但 NASH 中肝脏损伤的机制理解并不完全。在这里,我们使用一种具有人类 NASH 关键特征的临床前小鼠模型(以下简称 NASH 小鼠),发现 T 细胞在肝脏免疫病理学中起着不可或缺的作用。我们检测到具有组织驻留(CXCR6)与效应(颗粒酶)和衰竭(PD1)特征相结合表型的 CD8 T 细胞在肝脏中的积累。肝 CXCR6 CD8 T 细胞的 FOXO1 转录因子活性较低,在 NASH 小鼠和 NASH 患者中丰富存在。从机制上讲,IL-15 诱导 FOXO1 下调和 CXCR6 上调,共同使肝驻留 CXCR6 CD8 T 细胞对代谢刺激(包括醋酸盐和细胞外 ATP)敏感,并共同引发自身攻击。来自 NASH 小鼠或 NASH 患者肝脏的 CXCR6 CD8 T 细胞具有相似的转录特征,并且在通过 P2X7 嘌呤能受体信号传导后以 MHC 类-I 非依赖性方式对细胞进行自身攻击性杀伤。这种由自身攻击性 CD8 T 细胞引起的杀伤与抗原特异性细胞的杀伤根本不同,这从机制上区分了自身攻击性和保护性 T 细胞免疫。

相似文献

1
Auto-aggressive CXCR6 CD8 T cells cause liver immune pathology in NASH.自反应性 CXCR6+CD8 T 细胞导致 NASH 肝脏免疫病理。
Nature. 2021 Apr;592(7854):444-449. doi: 10.1038/s41586-021-03233-8. Epub 2021 Mar 24.
2
NASH limits anti-tumour surveillance in immunotherapy-treated HCC.NASH 限制了免疫治疗治疗 HCC 的肿瘤监测。
Nature. 2021 Apr;592(7854):450-456. doi: 10.1038/s41586-021-03362-0. Epub 2021 Mar 24.
3
CD8 T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease.CD8 T 细胞调节肥胖相关非酒精性脂肪性肝病中的肝损伤。
Am J Physiol Gastrointest Liver Physiol. 2020 Feb 1;318(2):G211-G224. doi: 10.1152/ajpgi.00040.2019. Epub 2019 Nov 11.
4
CXCR6 deficiency ameliorates ischemia-reperfusion injury by reducing the recruitment and cytokine production of hepatic NKT cells in a mouse model of non-alcoholic fatty liver disease.CXCR6 缺陷通过减少非酒精性脂肪性肝病小鼠模型中肝 NKT 细胞的募集和细胞因子产生来改善缺血再灌注损伤。
Int Immunopharmacol. 2019 Jul;72:224-234. doi: 10.1016/j.intimp.2019.04.021. Epub 2019 Apr 16.
5
Anti-CD122 antibody restores specific CD8 T cell response in nonalcoholic steatohepatitis and prevents hepatocellular carcinoma growth.抗 CD122 抗体可恢复非酒精性脂肪性肝炎中特异性 CD8 T 细胞应答,并防止肝细胞癌生长。
Oncoimmunology. 2023 Mar 2;12(1):2184991. doi: 10.1080/2162402X.2023.2184991. eCollection 2023.
6
CD8 tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells.CD8 组织驻留记忆 T 细胞通过诱导肝星状细胞凋亡促进肝纤维化消退。
Nat Commun. 2021 Jul 22;12(1):4474. doi: 10.1038/s41467-021-24734-0.
7
Diet Reversal and Immune Modulation Show Key Role for Liver and Adipose Tissue T Cells in Murine Nonalcoholic Steatohepatitis.饮食逆转和免疫调节显示肝脏和脂肪组织 T 细胞在小鼠非酒精性脂肪性肝炎中的关键作用。
Cell Mol Gastroenterol Hepatol. 2020;10(3):467-490. doi: 10.1016/j.jcmgh.2020.04.010. Epub 2020 Apr 29.
8
Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation.免疫反应在非酒精性脂肪性肝病相关肝癌的发生发展中的作用及治疗调节的前景。
J Hepatol. 2023 Aug;79(2):538-551. doi: 10.1016/j.jhep.2023.02.033. Epub 2023 Mar 7.
9
suppressing nonalcoholic steatohepatitis associated tumorigenesis through CXCR6 natural killer T cells.通过 CXCR6 自然杀伤 T 细胞抑制非酒精性脂肪性肝炎相关肿瘤发生。
Front Immunol. 2022 Dec 1;13:1047570. doi: 10.3389/fimmu.2022.1047570. eCollection 2022.
10
The immunoregulatory effects of CD8 T-cell-derived perforin on diet-induced nonalcoholic steatohepatitis.CD8 T 细胞来源的穿孔素对饮食诱导的非酒精性脂肪性肝炎的免疫调节作用。
FASEB J. 2019 Jul;33(7):8490-8503. doi: 10.1096/fj.201802534RR. Epub 2019 Apr 5.

引用本文的文献

1
Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesis.跨越脂肪肝疾病各阶段的人类肝脏和血液免疫细胞单细胞图谱揭示了与肝功能障碍和纤维化相关的独特特征。
Nat Immunol. 2025 Sep;26(9):1596-1611. doi: 10.1038/s41590-025-02255-y. Epub 2025 Aug 29.
2
Steatohepatitis alters lymphocytes cytotoxicity and localization, accelerating colorectal liver metastases.脂肪性肝炎会改变淋巴细胞的细胞毒性和定位,加速结直肠癌肝转移。
Neoplasia. 2025 Aug 28;69:101222. doi: 10.1016/j.neo.2025.101222.
3
Immunometabolic Targets in CD8 T Cells within the Tumor Microenvironment of Hepatocellular Carcinoma.

本文引用的文献

1
Reduced mitochondrial resilience enables non-canonical induction of apoptosis after TNF receptor signaling in virus-infected hepatocytes.线粒体弹性降低使得病毒感染的肝细胞在肿瘤坏死因子受体信号传导后能够非经典地诱导细胞凋亡。
J Hepatol. 2020 Dec;73(6):1347-1359. doi: 10.1016/j.jhep.2020.06.026. Epub 2020 Jun 26.
2
Single-cell RNA sequencing reveals the heterogeneity of liver-resident immune cells in human.单细胞RNA测序揭示了人类肝脏驻留免疫细胞的异质性。
Cell Discov. 2020 Apr 28;6:22. doi: 10.1038/s41421-020-0157-z. eCollection 2020.
3
The integrative biology of type 2 diabetes.
肝细胞癌肿瘤微环境中CD8 T细胞的免疫代谢靶点
Liver Cancer. 2024 Nov 21;14(4):474-496. doi: 10.1159/000542578. eCollection 2025 Aug.
4
The Intriguing Roles of Cytokines in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review.细胞因子在代谢功能障碍相关脂肪性肝病中的有趣作用:一篇叙述性综述
Curr Obes Rep. 2025 Aug 12;14(1):65. doi: 10.1007/s13679-025-00657-5.
5
Dynamic crosstalk between HSCs and liver microenvironment: multicellular interactions in the regulation of liver fibrosis.肝星状细胞与肝脏微环境之间的动态串扰:肝脏纤维化调控中的多细胞相互作用
Front Cell Dev Biol. 2025 Jul 21;13:1635763. doi: 10.3389/fcell.2025.1635763. eCollection 2025.
6
Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives.代谢功能障碍相关脂肪性肝病患者的肝脏硬度测量:方法有效性及前景的最新进展
World J Hepatol. 2025 Jul 27;17(7):106675. doi: 10.4254/wjh.v17.i7.106675.
7
Myeloid TGF-β signaling shapes liver macrophage heterogeneity and metabolic liver disease pathogenesis.髓系转化生长因子-β信号传导塑造肝脏巨噬细胞异质性和代谢性肝病发病机制。
JHEP Rep. 2025 Jun 19;7(8):101488. doi: 10.1016/j.jhepr.2025.101488. eCollection 2025 Aug.
8
Pathogenesis and management of metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma: a narrative review.代谢功能障碍相关脂肪性肝炎相关肝细胞癌的发病机制与管理:一篇叙述性综述
Ewha Med J. 2024 Oct;47(4):e65. doi: 10.12771/emj.2024.e65. Epub 2024 Oct 31.
9
The PNPLA3 I148M variant is associated with immune cell infiltration and advanced fibrosis in MASLD: a prospective genotype-phenotype study.PNPLA3 I148M变异与非酒精性脂肪性肝病合并代谢功能障碍相关脂肪性肝炎中的免疫细胞浸润和晚期纤维化有关:一项前瞻性基因型-表型研究。
J Gastroenterol. 2025 Jul 21. doi: 10.1007/s00535-025-02285-1.
10
Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病的抗纤维化治疗
JHEP Rep. 2025 Apr 11;7(8):101421. doi: 10.1016/j.jhepr.2025.101421. eCollection 2025 Aug.
2 型糖尿病的综合生物学。
Nature. 2019 Dec;576(7785):51-60. doi: 10.1038/s41586-019-1797-8. Epub 2019 Dec 4.
4
The Unexpected Role of Neutrophils for Resolving Liver Inflammation by Transmitting MicroRNA-223 to Macrophages.中性粒细胞通过向巨噬细胞传递微小RNA-223在解决肝脏炎症中发挥的意外作用。
Hepatology. 2020 Feb;71(2):749-751. doi: 10.1002/hep.30925. Epub 2019 Dec 31.
5
Microbiota-Derived Short-Chain Fatty Acids Promote the Memory Potential of Antigen-Activated CD8 T Cells.微生物群衍生的短链脂肪酸促进抗原激活的 CD8 T 细胞的记忆潜能。
Immunity. 2019 Aug 20;51(2):285-297.e5. doi: 10.1016/j.immuni.2019.06.002. Epub 2019 Jul 1.
6
TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection.TOX 增强慢性病毒感染中耗竭 T 细胞的表型和寿命。
Nature. 2019 Jul;571(7764):265-269. doi: 10.1038/s41586-019-1326-9. Epub 2019 Jun 17.
7
TOX transcriptionally and epigenetically programs CD8 T cell exhaustion.TOX 在转录和表观遗传水平上对 CD8 T 细胞衰竭进行编程。
Nature. 2019 Jul;571(7764):211-218. doi: 10.1038/s41586-019-1325-x. Epub 2019 Jun 17.
8
Comprehensive Integration of Single-Cell Data.单细胞数据的综合整合。
Cell. 2019 Jun 13;177(7):1888-1902.e21. doi: 10.1016/j.cell.2019.05.031. Epub 2019 Jun 6.
9
GREIN: An Interactive Web Platform for Re-analyzing GEO RNA-seq Data.GREIN:一个用于重新分析 GEO RNA-seq 数据的交互式网络平台。
Sci Rep. 2019 May 20;9(1):7580. doi: 10.1038/s41598-019-43935-8.
10
Acetate Promotes T Cell Effector Function during Glucose Restriction.醋酸盐在葡萄糖限制期间促进 T 细胞效应功能。
Cell Rep. 2019 May 14;27(7):2063-2074.e5. doi: 10.1016/j.celrep.2019.04.022.